T-cell Immunodeficiency, Congenital Alopecia, and Nail Dystrophy

Genetic MONDO:0011132 Pathograph 14 Show in embeddings browser Severe combined immunodeficiency Primary immunodeficiency Congenital athymia

Human nude SCID is an autosomal recessive inborn error of immunity caused by biallelic loss-of-function variants in FOXN1, the winged-helix (forkhead) transcription factor mutated at the nude locus of mice and rats. FOXN1 is expressed in thymic epithelium and in terminally differentiating skin epithelium, and its loss produces a single-gene lesion with two anatomically separate consequences. In the thymic anlage, thymic epithelial cells fail to differentiate, so no functional thymic microenvironment forms; the resulting athymia abolishes thymopoiesis and produces profound T-cell lymphopenia with numerically preserved B and NK cells, presenting in the first months of life as severe, recurrent, life-threatening infection. In the skin, loss of the same factor disrupts the growth-differentiation balance of keratinocytes in hair follicles and nail bed, producing congenital alopecia universalis and nail dystrophy (characteristically proximal arciform leukonychia and koilonychia). Because the defect is in thymic stroma rather than in hematopoietic stem cells, hematopoietic cell transplantation does not reconstitute thymopoiesis unless the graft itself carries mature donor T cells, and cultured thymus tissue implantation is the mechanism-directed treatment. The disease is ultra-rare; most reported patients descend from a single R255X founder pedigree in Acerno, southern Italy. Cross-references: OMIM:601705, Orphanet ORPHA:169095. Two adjacent FOXN1-related entities are deliberately NOT covered by this entry. (1) FOXN1 haploinsufficiency (OMIM 600838), an autosomal dominant condition in which heterozygous carriers are ascertained through low TRECs on newborn screening and show T-cell lymphopenia that improves with age, usually with normal or near-normal hair and only subtle nail dystrophy; IUIS lists it as a separate row from the AR disease. (2) Compound heterozygous hypomorphic FOXN1 genotypes, which can produce selective thymic hypoplasia with entirely normal hair and nails. Both are described in the genetic and notes sections here only to keep the boundary of this entry explicit.

Ask OpenScientist

Ask a research question about T-cell Immunodeficiency, Congenital Alopecia, and Nail Dystrophy. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
7
Pathophys.
11
Phenotypes
14
Pathograph
2
Genes
5
Medical Actions
1
References
🏷

Classifications

Harrison's Part
IMMUNE RHEUMATOLOGIC GENETICS ENVIRONMENT DISEASE
IUIS Category
combined immunodeficiency with syndromic features
👪

Inheritance

1
Autosomal recessive HP:0000007
Nude SCID is caused by biallelic loss-of-function variants in FOXN1. Heterozygous carriers of the R255X founder allele are healthy with respect to the full triad, which is what allowed a 6.52% carrier frequency to persist in the Acerno pedigree.
Autosomal recessive inheritance
Show evidence (2 references)
PMID:28077132 SUPPORT Human Clinical
"Nude severe combined immunodeficiency is a rare inherited disease caused by autosomal recessive loss-of-function mutations in FOXN1."
States the autosomal recessive, loss-of-function basis of the disease.
PMID:8911612 SUPPORT Human Clinical
"We report on two sisters affected by congenital alopecia, nail dystrophy, and a severe T-cell immunodeficiency, presumably inherited as an autosomal-recessive disorder."
The original clinical report of the syndrome in two affected sibs, from which autosomal recessive inheritance was inferred.
⚙

Pathophysiology

7
FOXN1 Transcription Factor Loss of Function
Biallelic loss-of-function variants abolish FOXN1 transcription-factor activity. FOXN1 is a winged-helix (forkhead) DNA-binding transcription factor; the nonsense and frameshift alleles that cause human nude SCID remove or inactivate the DNA-binding domain, so the FOXN1 target gene program is not transcribed. This is the initiating lesion, and every downstream node - thymic and cutaneous alike - follows from the absence of this single transcriptional output rather than from any defect intrinsic to hematopoietic cells.
FOXN1 hgnc:12765 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves FOXN1 (hgnc:12765). hgnc:12765 is a gene from the HUGO Gene Nomenclature Committee.
Genetic context variant_origin: GERMLINE zygosity: HOMOZYGOUS functional_impact_category: LOSS_OF_FUNCTION
Germline biallelic loss-of-function FOXN1 alleles; the prototype and most frequently reported allele is the nonsense variant R255X.
FOXN1 winged-helix transcription factor activity GO:0003700 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves FOXN1 winged-helix transcription factor activity, annotated with DNA-binding transcription factor activity (GO:0003700), qualified as loss of function. GO:0003700 is a molecular function from the Gene Ontology. ⇓ LOSS OF FUNCTION
Show evidence (4 references)
PMID:28077132 SUPPORT Human Clinical
"This gene encodes a transcription factor essential for the development of the thymus, the primary lymphoid organ that supports T-cell development and selection."
Identifies FOXN1 as a transcription factor and establishes that its transcriptional output is what thymic development depends on.
PMID:7969402 SUPPORT Model Organism
"Here we show that one of the genes from this critical region, designated whn, encodes a new member of the winged-helix domain family of transcription factors, and that it is disrupted on mouse nu and rat rnuN alleles."
Identifies the nude gene as a winged-helix transcription factor, the molecular identity of FOXN1 and the origin of the "winged-helix-nude" name.
PMID:7969402 SUPPORT Model Organism
"Mutant transcripts do not encode the characteristic DNA-binding domain, strongly suggesting that the whn gene is the nude gene."
Establishes that the nude alleles act by removing the DNA-binding domain, i.e. by abolishing transcription-factor function.
+ 1 more reference
Failed Thymic Epithelial Cell Differentiation
Without FOXN1, thymic epithelial cells fail to differentiate into the cortical and medullary subsets that constitute the thymic microenvironment. Cortical TECs normally mediate positive selection of T-cell precursors and medullary TECs negative selection; neither compartment forms. This is a stromal, non-hematopoietic defect, which is the single most important mechanistic fact about the disease for treatment selection.
thymic epithelial cell CL:0002293 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves thymic epithelial cell, annotated with epithelial cell of thymus (CL:0002293). CL:0002293 is a cell type from the Cell Ontology. cortical thymic epithelial cell CL:0002364 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves cortical thymic epithelial cell (CL:0002364). CL:0002364 is a cell type from the Cell Ontology. medullary thymic epithelial cell CL:0002365 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves medullary thymic epithelial cell (CL:0002365). CL:0002365 is a cell type from the Cell Ontology.
thymic epithelial cell differentiation GO:0030855 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased thymic epithelial cell differentiation, annotated with epithelial cell differentiation (GO:0030855). GO:0030855 is a biological process from the Gene Ontology. ↓ DECREASED thymus epithelium morphogenesis GO:0097536 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased thymus epithelium morphogenesis (GO:0097536). GO:0097536 is a biological process from the Gene Ontology. ↓ DECREASED
thymus UBERON:0002370 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in thymus (UBERON:0002370). UBERON:0002370 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (3 references)
PMID:31566583 SUPPORT Human Clinical
"We report on 2 patients with compound heterozygous mutations in forkhead box N1 (FOXN1), a transcription factor essential for thymic epithelial cell (TEC) differentiation."
Identifies TEC differentiation as the FOXN1-dependent cellular process that fails.
PMID:31566583 SUPPORT In Vitro
"Characterization of the functional changes due to the Foxn1 mutations revealed a 5-amino acid segment at the end of the DNA-binding domain essential for the development of TECs but not keratinocytes."
Functional dissection showing that distinct parts of the FOXN1 DNA-binding domain are required for the thymic and cutaneous arms, which is why hypomorphic genotypes can dissociate the two.
PMID:36648576 SUPPORT Other
"the growth and differentiation of skin epithelial cells, including hair and nails"
In the thymic-defect guideline's FOXN1 section, this clause names the cutaneous half of the FOXN1-dependent epithelial program, alongside the thymic epithelial cells named in the preceding clause.
Athymia
Congenital absence of a functional thymus. This is thymic aplasia proper - the organ never forms - as distinguished from the thymic hypoplasia seen in hematopoietic-intrinsic SCID, where an epithelial rudiment is present but is not populated by thymocytes.
thymus development GO:0048538 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased thymus development (GO:0048538). GO:0048538 is a biological process from the Gene Ontology. ↓ DECREASED
thymus UBERON:0002370 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in thymus (UBERON:0002370). UBERON:0002370 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (2 references)
PMID:20978268 SUPPORT Human Clinical
"FOXN1 deficiency is a primary immunodeficiency characterized by athymia, alopecia totalis, and nail dystrophy."
Names athymia as the defining thymic lesion of FOXN1 deficiency.
PMID:18339010 SUPPORT Human Clinical
"We identified a human fetus homozygous for a mutation in FOXN1 gene who lacked the thymus and also had abnormal skin, anencephaly and spina bifida."
Direct anatomical confirmation, in a homozygous human fetus, that the thymus is absent rather than merely small.
Absent Thymopoiesis
T-cell precursors arriving from the bone marrow have no thymic epithelial niche to interact with, so intrathymic T-cell differentiation does not occur. The hematopoietic stem cell compartment itself is normal - the block is entirely extrinsic to it.
T cell CL:0000084 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves T cell (CL:0000084). CL:0000084 is a cell type from the Cell Ontology.
T cell differentiation in thymus GO:0033077 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased T cell differentiation in thymus (GO:0033077). GO:0033077 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (2 references)
PMID:36648576 SUPPORT Other
"leading to profound TCL. Affected individuals also have alopecia and dysplastic nails"
The guideline states that autosomal recessive FOXN1 deficiency blocks the interaction of T-cell precursors with cortical and medullary thymic epithelium, producing profound T-cell lymphopenia.
PMID:20978268 SUPPORT Human Clinical
"Subject 1 presented with disseminated Bacillus Calmette-Guérin infection and oligoclonal T cells with no naive markers."
Absence of naive-marker T cells is the direct cellular readout of absent thymic output.
Profound T-Cell Lymphopenia
The immunophenotype is T-negative with numerically preserved B and NK cells (T-B+NK+). B cells are present but antibody production is compromised because T-cell help is absent, so humoral as well as cellular immunity fails despite a normal B-cell count. This is why the entity is a combined immunodeficiency rather than a pure T-cell defect.
T cell CL:0000084 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves T cell (CL:0000084). CL:0000084 is a cell type from the Cell Ontology.
T cell homeostasis GO:0043029 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased T cell homeostasis (GO:0043029). GO:0043029 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (2 references)
PMID:28077132 SUPPORT Human Clinical
"To date nine cases have been reported presenting with the clinical triad of absent thymus resulting in severe T-cell immunodeficiency, congenital alopecia universalis and nail dystrophy."
States that the severe T-cell immunodeficiency is the consequence of the absent thymus.
PMID:28077132 SUPPORT Human Clinical
"Although B-cells are typically present in normal numbers, antibody production is compromised in the absence of T-cell help"
Documents the B+ immunophenotype and explains why preserved B-cell numbers do not confer functional humoral immunity.
Severe Recurrent Infection
Severe, recurrent, life-threatening infection beginning in the first months of life is the presenting feature and, untreated, the cause of death. Disseminated BCG disease has been reported where BCG was given before the immunodeficiency was recognised.
defense response GO:0006952 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased defense response (GO:0006952). GO:0006952 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (2 references)
PMID:28077132 SUPPORT Human Clinical
"Without these the prognosis is poor due to early-onset life threatening infections."
Establishes early-onset life-threatening infection as the cause of the poor untreated prognosis.
PMID:15180707 SUPPORT Human Clinical
"In this community, four additional children affected with congenital alopecia died in early childhood because of severe infections."
Documents early-childhood death from severe infection in affected members of the founder pedigree.
Impaired Keratinocyte Terminal Differentiation
FOXN1 is expressed in skin epithelial cells that have exited the cell cycle and are undergoing terminal differentiation, where it controls expression of kinases governing cell survival, metabolism and cell-cycle progression. Its loss disrupts the balance between growth and differentiation in these cells. Notably, hair follicles are present in normal numbers - the defect is in the differentiated product, not in follicle formation.
keratinocyte CL:0000312 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves keratinocyte (CL:0000312). CL:0000312 is a cell type from the Cell Ontology.
keratinocyte differentiation GO:0030216 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased keratinocyte differentiation (GO:0030216). GO:0030216 is a biological process from the Gene Ontology. ↓ DECREASED hair follicle development GO:0001942 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased hair follicle development (GO:0001942). GO:0001942 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (3 references)
PMID:28077132 SUPPORT Human Clinical
"In the skin and its appendages FOXN1 is expressed in epithelial cells that have stopped proliferating and are in the process of terminal differentiation"
Locates FOXN1 function in terminally differentiating skin epithelium.
PMID:28077132 SUPPORT Human Clinical
"As a consequence, loss-of-function mutations disrupt the balance between normal growth and differentiation of these cells"
States the cellular consequence of FOXN1 loss in keratinocytes.
PMID:7969402 SUPPORT Model Organism
"Mutations at the nude locus of mice and rats disrupt normal hair growth and thymus development, causing nude mice and rats to be immune-deficient."
The animal nude phenotype couples the same two arms - hair and thymus - confirming a shared single-gene origin.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for T-cell Immunodeficiency, Congenital Alopecia, and Nail Dystrophy Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

11
Blood 1
Profound T-Cell Lymphopenia VERY_FREQUENT Decreased total T cell count HP:0005403 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Decreased total T cell count (HP:0005403). HP:0005403 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:20978268 SUPPORT Human Clinical
"Subject 2 had respiratory failure, human herpes virus 6 infection, cytopenias, and no circulating T cells."
Documents complete absence of circulating T cells in a FOXN1-deficient infant.
PMID:28077132 SUPPORT Human Clinical
"To date nine cases have been reported presenting with the clinical triad of absent thymus resulting in severe T-cell immunodeficiency, congenital alopecia universalis and nail dystrophy."
Severe T-cell immunodeficiency is one of the three defining features present in every reported case, supporting a very frequent band.
Cardiovascular 1
Athymia VERY_FREQUENT Aplasia of the thymus HP:0005359 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Aplasia of the thymus (HP:0005359). HP:0005359 is a phenotype from the Human Phenotype Ontology.
Aplasia, not hypoplasia: in FOXN1 deficiency the thymic epithelial primordium fails to differentiate, so the organ does not form. This is the distinction drawn in the Severe_Combined_Immunodeficiency entry, where HP:0000778 Hypoplasia of the thymus is used because a rudiment is present but unpopulated.
Show evidence (2 references)
PMID:18339010 SUPPORT Human Clinical
"We identified a human fetus homozygous for a mutation in FOXN1 gene who lacked the thymus and also had abnormal skin, anencephaly and spina bifida."
Anatomical confirmation of absent thymus in a homozygous human fetus.
PMID:28077132 SUPPORT Human Clinical
"To date nine cases have been reported presenting with the clinical triad of absent thymus resulting in severe T-cell immunodeficiency, congenital alopecia universalis and nail dystrophy."
Absent thymus is one of the three features present in the reported case series, supporting the very frequent band.
Immune 3
Severe Combined Immunodeficiency Phenotype HP:0004430 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Severe combined immunodeficiency (HP:0004430). HP:0004430 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33464451 SUPPORT Human Clinical
"Human nude SCID is a rare autosomal recessive inborn error of immunity (IEI) characterized by congenital athymia, alopecia, and nail dystrophy."
Establishes the SCID classification of the disease.
Severe Recurrent Infection from Birth VERY_FREQUENT Recurrent infections HP:0002719 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Recurrent severe infections, annotated with Recurrent infections (HP:0002719), qualified as temporality recurrent; severity severe. HP:0002719 is a phenotype from the Human Phenotype Ontology.
Temporal: RECURRENT Severity: SEVERE
Show evidence (2 references)
PMID:28077132 SUPPORT Human Clinical
"All reported patients presented in the first months of life with severe, recurrent, life-threatening infections"
"All reported patients" supports the very frequent (80-100%) band as well as the phenotype itself.
PMID:20978268 SUPPORT Human Clinical
"Subject 1 presented with disseminated Bacillus Calmette-Guérin infection and oligoclonal T cells with no naive markers."
Illustrates disseminated live-vaccine (BCG) disease as a presenting infection.
Omenn Syndrome Features FREQUENT Erythroderma HP:0001019 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Erythroderma (Omenn-like presentation), annotated with Erythroderma (HP:0001019). HP:0001019 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33464451 SUPPORT Human Clinical
"Nail dystrophy and alopecia, that represent the hallmarks of the syndrome, were not always present, while almost 50% of the patients developed Omenn syndrome."
Quantifies Omenn syndrome at almost 50% of the surveyed cohort, supporting the frequent (30-79%) band, and simultaneously documents that the dermatological hallmarks are not invariant.
Integument 4
Congenital Alopecia Universalis VERY_FREQUENT HP:0002289 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Congenital alopecia universalis, annotated with Alopecia universalis (HP:0002289), qualified as congenital onset. HP:0002289 is a phenotype from the Human Phenotype Ontology.
Onset: CONGENITAL
Not invariant. In a large international survey of FOXN1 genotypes, alopecia and nail dystrophy were "not always present", so the very frequent band reflects the classic triad rather than a universal finding.
Show evidence (2 references)
PMID:28077132 SUPPORT Human Clinical
"Dermatological features include congenital alopecia affecting the scalp, eyebrows and eyelashes"
Documents the distribution of the congenital alopecia.
PMID:8911612 SUPPORT Human Clinical
"We report on two sisters affected by congenital alopecia, nail dystrophy, and a severe T-cell immunodeficiency, presumably inherited as an autosomal-recessive disorder."
The original report establishing congenital alopecia as a core feature.
Nail Dystrophy VERY_FREQUENT HP:0008404 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Nail dystrophy (HP:0008404), qualified as congenital onset. HP:0008404 is a phenotype from the Human Phenotype Ontology.
Onset: CONGENITAL
Show evidence (2 references)
PMID:28077132 SUPPORT Human Clinical
"The latter most frequently features proximal arciform leukonychia and koilonychia"
Specifies the characteristic nail changes.
PMID:20978268 SUPPORT Human Clinical
"FOXN1 deficiency is a primary immunodeficiency characterized by athymia, alopecia totalis, and nail dystrophy."
Nail dystrophy is one of the three characterizing features.
Leukonychia HP:0001820 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Proximal arciform leukonychia, annotated with Leukonychia (HP:0001820). HP:0001820 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:28077132 SUPPORT Human Clinical
"The latter most frequently features proximal arciform leukonychia and koilonychia"
Names proximal arciform leukonychia as a most-frequent nail finding.
Koilonychia Concave nail HP:0001598 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Koilonychia, annotated with Concave nail (HP:0001598). HP:0001598 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:28077132 SUPPORT Human Clinical
"The latter most frequently features proximal arciform leukonychia and koilonychia"
Names koilonychia as a most-frequent nail finding.
Nervous System 2
Neural Tube Defect VERY_RARE HP:0045005 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Neural tube defect (HP:0045005). HP:0045005 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:18339010 SUPPORT Human Clinical
"We identified a human fetus homozygous for a mutation in FOXN1 gene who lacked the thymus and also had abnormal skin, anencephaly and spina bifida."
Documents anencephaly and spina bifida in a homozygous FOXN1 fetus.
PMID:18339010 SUPPORT INDIRECT Model Organism
"Moreover, we found that FOXN1 gene is expressed in mouse developing choroid plexus. These observations suggest that FOXN1 may be involved in neurulation in humans."
Provides the model-organism expression evidence behind the proposed role in neurulation. Indirect: the quote reports mouse choroid-plexus expression and an inference, not an observed human neural tube defect, which rests on the fetal case in the companion evidence item.
Anencephaly VERY_RARE HP:0002323 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Anencephaly (HP:0002323). HP:0002323 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:18339010 SUPPORT Human Clinical
"We identified a human fetus homozygous for a mutation in FOXN1 gene who lacked the thymus and also had abnormal skin, anencephaly and spina bifida."
Documents anencephaly in a homozygous FOXN1 fetus.
🧬

Genetic Associations

2
FOXN1 (CAUSATIVE)
Gene: FOXN1 hgnc:12765 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is FOXN1 (hgnc:12765). hgnc:12765 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Show evidence (3 references)
PMID:28077132 SUPPORT Human Clinical
"Nude severe combined immunodeficiency is a rare inherited disease caused by autosomal recessive loss-of-function mutations in FOXN1."
Establishes FOXN1 as the causative gene and loss of function as the mechanism.
PMID:15180707 SUPPORT Human Clinical
"The first described human FOXN1 mutation was a C792T transition in exon 5 resulting in the nonsense mutation R255X, and was detected in two probands originated from a small community in southern Italy."
Identifies the prototype human allele and its geographic origin.
PMID:15180707 SUPPORT Human Clinical
"The three haplotypes identified, 3/R255X/3, 3/R255X/2 and 3/R255X/1, are consistent with a single ancestral origin for the mutation R255X."
Haplotype analysis establishing R255X as a single ancestral founder allele.
FOXN1 (heterozygous - distinct entity, not this disease) (MODIFIER)
Gene: FOXN1 hgnc:12765 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is FOXN1 (hgnc:12765). hgnc:12765 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: MODIFIER
Show evidence (3 references)
PMID:31447097 SUPPORT Human Clinical
"We identified several newborns with low levels of T cell receptor excision circles (TRECs) and T cell lymphopenia at birth, who carried heterozygous loss-of-function FOXN1 variants."
Documents the heterozygous newborn-screening phenotype that defines the separate haploinsufficiency entity.
PMID:31447097 SUPPORT Human Clinical
"Longitudinal analysis showed persistent T cell lymphopenia during infancy, often associated with nail dystrophy."
Characterizes the milder, age-limited heterozygous phenotype, distinct from the congenital athymia of the recessive disease.
PMID:36648576 SUPPORT Other
"Congenital athymia is generally not present, and individuals have normal or almost normal appearing hair with only subtle nail dystrophy (spoon nails)."
The guideline states explicitly that heterozygous FOXN1 carriers lack the athymia and the ectodermal hallmarks that define this entry's disease.
💊

Medical Actions

5
Cultured Thymus Tissue Implantation
Action: cultured thymus tissue implantationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is cultured thymus tissue implantation, annotated with Organ Transplantation (NCIT:C15289). NCIT:C15289 is a clinical intervention from the NCI Thesaurus. Ontology label: Organ Transplantation NCIT:C15289
Platform: Surgery
Implantation of cultured allogeneic postnatal thymus tissue (obtained from infants undergoing corrective cardiac surgery) into the quadriceps muscle. This is the mechanism-directed treatment for nude SCID: because FOXN1 is expressed in thymic epithelium and not in hematopoietic cells, supplying a functional thymic stromal environment - rather than replacing the patient's own normal hematopoietic compartment - is what restores thymopoiesis. HLA matching is not required. Reconstitution is slow, typically taking six to twelve months, so supportive infection prophylaxis must bridge that interval. Autoimmunity, principally thyroid, is a recognised late complication.
Mechanism Target:
RESTORES Athymia — The implant supplies the thymic epithelial microenvironment the patient never formed, directly addressing the athymia node rather than any hematopoietic step.
Show evidence (1 reference)
PMID:28077132 SUPPORT Human Clinical
"Given that FOXN1 is expressed in TECs and not haematopoietic cells, establishing a functional thymic stromal environment is expected to provide more complete and long-lasting immune reconstitution"
States the mechanistic rationale for treating the stromal defect directly.
RESTORES Absent Thymopoiesis — Once a thymic microenvironment is present, host T-cell precursors undergo normal intrathymic development, producing naive T cells and TREC-positive recent thymic emigrants.
Show evidence (1 reference)
PMID:20978268 SUPPORT Human Clinical
"In summary, thymus transplantation led to T-cell reconstitution and function in these FOXN1 deficient infants."
Demonstrates restored thymopoiesis in the two FOXN1-deficient infants treated.
Target Phenotypes: Aplasia of the thymus HP:0005359 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Aplasia of the thymus (HP:0005359). HP:0005359 is a phenotype from the Human Phenotype Ontology. Decreased total T cell count HP:0005403 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Decreased total T cell count (HP:0005403). HP:0005403 is a phenotype from the Human Phenotype Ontology.
Show evidence (5 references)
PMID:20978268 SUPPORT Human Clinical
"Two infants with FOXN1 deficiency were transplanted with cultured postnatal thymus tissue."
The first application of cultured thymus tissue specifically in FOXN1 deficiency.
PMID:20978268 SUPPORT Human Clinical
"Both subjects developed functional immunity. Subjects 1 and 2 have 1053/mm(3) and 1232/mm(3) CD3(+) cells"
Quantifies the reconstituted T-cell compartment achieved in both treated FOXN1-deficient infants.
PMID:34362576 SUPPORT Human Clinical
"Treatment with CTT led to development of naive T cells with a 1-year survival rate of 77% and a median follow-up time of 7.6 years."
Provides the pooled efficacy and survival estimate across the full congenital-athymia cohort, which includes FOXN1 deficiency.
+ 2 more references
Hematopoietic Cell Transplantation
Action: hematopoietic cell transplantationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is hematopoietic cell transplantation (NCIT:C15431). NCIT:C15431 is a clinical intervention from the NCI Thesaurus. Ontology label: Hematopoietic Cell Transplantation NCIT:C15431
Platform: Cell therapy
Allogeneic HCT does not correct the underlying lesion, because FOXN1 is expressed in thymic stroma and not in hematopoietic cells - transplanting normal stem cells into a patient with no thymus leaves them with nowhere to differentiate. Where HCT has helped in nude SCID, the benefit is attributed to mature donor T cells carried in the graft rather than to restored thymopoiesis, which is why the literature restricts it to HLA-matched genoidentical sibling donors, and why it is preferred chiefly when thymus tissue is unavailable or when rapid T-cell recovery is needed for a pre-existing systemic viral infection. Outcomes reported for athymia treated with HCT are poor.
Mechanism Target:
MODULATES Profound T-Cell Lymphopenia — A genoidentical graft can supply mature donor T cells that partially populate the periphery. It does not act on the athymia or the thymopoiesis block upstream of it, so the effect is compensatory rather than restorative.
Show evidence (1 reference)
PMID:28077132 SUPPORT Human Clinical
"whereas the other was alive and infection-free when assessed 6 years later likely due to the presence of mature donor T-cells"
Describes the surviving HCT recipient among the two treated; the review attributes the outcome to mature donor T cells present in the bone marrow graft rather than to restored thymic function — the mechanistic point behind typing this treatment MODULATES rather than RESTORES.
Show evidence (4 references)
PMID:28077132 SUPPORT Human Clinical
"Options for treating the underlying immune deficiency include HLA-matched genoidentical haematopoietic cell transplantation containing mature donor T-cells or thymus tissue transplantation."
Identifies the two definitive options and specifies that the HCT option depends on mature donor T cells in the graft.
PMID:28077132 SUPPORT Human Clinical
"Given that FOXN1 is expressed in TECs and not haematopoietic cells, establishing a functional thymic stromal environment is expected to provide more complete and long-lasting immune reconstitution"
States why replacing the hematopoietic compartment is not expected to provide complete reconstitution in a thymic stromal defect.
PMID:34362576 SUPPORT INDIRECT Human Clinical
"only 7 of 17 patients (41%) were reported as surviving by Janda et al."
Reports the survival figure for congenital athymia treated with hematopoietic stem cell transplantation, the comparator against which cultured thymus tissue is assessed. Indirect because this is the congenital-athymia cohort broadly, not a FOXN1-only series.
+ 1 more reference
Infection Prophylaxis and Protective Isolation
Action: antimicrobial prophylaxisNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is antimicrobial prophylaxis, annotated with Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. Ontology label: Pharmacotherapy NCIT:C15986
Platform: Small molecule
Supportive management that bridges the interval before and after definitive treatment: protective isolation in a laminar-flow room, prophylaxis against Pneumocystis jirovecii, fungal and viral infection, and anti-mycobacterial treatment for any infant already immunised with BCG. Live vaccines are contraindicated. Blood products, if required, must be CMV-negative, irradiated and leucocyte-depleted.
Mechanism Target:
INHIBITS Severe Recurrent Infection — Prophylaxis and isolation act on the infectious consequence of the immunodeficiency; they do not touch the thymic lesion upstream.
Show evidence (1 reference)
PMID:34362576 SUPPORT Human Clinical
"Currently, the only available treatment for these patients, outside of a clinical trial, is supportive care, which may include strict infection-prevention measures including immunoglobulin replacement, prophylactic antimicrobials, and protective isolation."
Names the supportive components and their role in congenital athymia outside definitive therapy.
Show evidence (2 references)
PMID:34362576 SUPPORT Human Clinical
"Currently, the only available treatment for these patients, outside of a clinical trial, is supportive care, which may include strict infection-prevention measures including immunoglobulin replacement, prophylactic antimicrobials, and protective isolation."
Establishes supportive infection prevention as the standing management for congenital athymia.
PMID:28077132 SUPPORT Human Clinical
"This involves isolation in a laminar flow room, prophylaxis against"
The disease review specifies laminar-flow isolation and infection prophylaxis as the supportive regimen for nude SCID.
Immunoglobulin Replacement Therapy
Action: immunoglobulin replacement therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is immunoglobulin replacement therapy, annotated with Immunoglobulin Therapy (NCIT:C62710). NCIT:C62710 is a clinical intervention from the NCI Thesaurus. Ontology label: Immunoglobulin Therapy NCIT:C62710
Platform: Other
Immunoglobulin replacement compensates for the absent T-dependent antibody response. B cells are numerically normal in nude SCID, so the humoral defect is functional rather than quantitative; replacement addresses that functional gap and can be discontinued once thymic reconstitution restores T-cell help.
Mechanism Target:
MODULATES Profound T-Cell Lymphopenia — Replacement immunoglobulin substitutes for the antibody responses the patient cannot mount without T-cell help. It compensates for a downstream consequence and does not alter the thymic lesion.
Show evidence (1 reference)
PMID:20978268 SUPPORT Human Clinical
"Both subjects developed antigen-specific proliferative responses and have discontinued immunoglobulin replacement."
Shows that immunoglobulin replacement was the standing substitute for T-dependent antibody responses and became unnecessary once thymic function was restored.
Show evidence (1 reference)
PMID:34362576 SUPPORT Human Clinical
"Currently, the only available treatment for these patients, outside of a clinical trial, is supportive care, which may include strict infection-prevention measures including immunoglobulin replacement, prophylactic antimicrobials, and protective isolation."
Names immunoglobulin replacement as a component of supportive care in congenital athymia.
Genetic Counseling and Carrier Testing
Action: genetic counselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is genetic counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. Ontology label: Genetic Counseling NCIT:C15240
Platform: Behavioral / lifestyle
FOXN1 sequencing establishes the diagnosis, guides therapeutic management, and enables counselling. In the Acerno pedigree, targeted PCR for the known R255X allele supported population-level carrier screening.
Show evidence (2 references)
PMID:28077132 SUPPORT Human Clinical
"Diagnosis relies on testing for FOXN1 mutations, which allows genetic counselling and guides therapeutic management."
States the role of molecular diagnosis in counselling and management.
PMID:15180707 SUPPORT Human Clinical
"In this study, we report on the screening for this mutation in 30% of the village population."
Documents founder-allele carrier screening at population scale in the affected community.
📊

Prevalence

2
Worldwide
Cases In Literature Ultra Rare
Ultra-rare. As of the 2017 disease review, nine cases had been reported in the literature, six of them from the single Acerno founder pedigree in southern Italy. Newborn screening and next-generation sequencing have since identified additional and atypical cases, so the true incidence is thought to be higher than the historical case count implies. Orphanet code ORPHA:169095; no ORPHA structured cache entry was built for this entry.
Show evidence (2 references)
PMID:28077132 SUPPORT Human Clinical
"Nude severe combined immunodeficiency is a rare inherited disease caused by autosomal recessive loss-of-function mutations in FOXN1. This gene encodes a transcription factor essential for the development of the thymus, the primary lymphoid organ that supports T-cell development and selection. To..."
The review reports nine FOXN1-associated nude SCID cases, including six from Acerno with the same founder mutation. The quoted count is the literature available to that review.
PMID:33464451 SUPPORT INDIRECT Human Clinical
"However, the recent introduction of newborn screening for IEIs and high-throughput sequencing has led to the identification of novel and atypical cases."
Supports this record's caveat that ascertainment has improved, so published case totals understate true occurrence. Indirect: the quote speaks to the completeness of case finding rather than reporting any occurrence figure of its own.
Acerno, southern Italy (R255X carrier screening)
Carrier Frequency 6520.0 per 100,000 >1 in 1,000 (carriers)
Carrier frequency of the R255X founder allele, not disease prevalence: 55 heterozygous carriers among 843 screened inhabitants (6.52%), all linked in a seven-generation pedigree descending from one ancestral couple.
Show evidence (1 reference)
PMID:15180707 SUPPORT Human Clinical
"This analysis led us to identify 55 heterozygous carriers (6.52%) of the R255X mutation out of 843 inhabitants screened."
Directly reports the carrier count, denominator and percentage behind this carrier-frequency record.
{ }

Source YAML

click to show
name: T-cell Immunodeficiency, Congenital Alopecia, and Nail Dystrophy
creation_date: '2026-08-26T00:00:00Z'
category: Genetic
synonyms:
- nude SCID
- FOXN1 deficiency
- alymphoid cystic thymic dysgenesis
- winged-helix-nude
- winged helix deficiency
- severe T-cell immunodeficiency-congenital alopecia-nail dystrophy syndrome
description: >-
  Human nude SCID is an autosomal recessive inborn error of immunity caused by
  biallelic loss-of-function variants in FOXN1, the winged-helix (forkhead)
  transcription factor mutated at the nude locus of mice and rats. FOXN1 is
  expressed in thymic epithelium and in terminally differentiating skin
  epithelium, and its loss produces a single-gene lesion with two anatomically
  separate consequences. In the thymic anlage, thymic epithelial cells fail to
  differentiate, so no functional thymic microenvironment forms; the resulting
  athymia abolishes thymopoiesis and produces profound T-cell lymphopenia with
  numerically preserved B and NK cells, presenting in the first months of life
  as severe, recurrent, life-threatening infection. In the skin, loss of the
  same factor disrupts the growth-differentiation balance of keratinocytes in
  hair follicles and nail bed, producing congenital alopecia universalis and
  nail dystrophy (characteristically proximal arciform leukonychia and
  koilonychia). Because the defect is in thymic stroma rather than in
  hematopoietic stem cells, hematopoietic cell transplantation does not
  reconstitute thymopoiesis unless the graft itself carries mature donor T
  cells, and cultured thymus tissue implantation is the mechanism-directed
  treatment. The disease is ultra-rare; most reported patients descend from a
  single R255X founder pedigree in Acerno, southern Italy. Cross-references:
  OMIM:601705, Orphanet ORPHA:169095.

  Two adjacent FOXN1-related entities are deliberately NOT covered by this
  entry. (1) FOXN1 haploinsufficiency (OMIM 600838), an autosomal dominant
  condition in which heterozygous carriers are ascertained through low TRECs on
  newborn screening and show T-cell lymphopenia that improves with age, usually
  with normal or near-normal hair and only subtle nail dystrophy; IUIS lists it
  as a separate row from the AR disease. (2) Compound heterozygous hypomorphic
  FOXN1 genotypes, which can produce selective thymic hypoplasia with entirely
  normal hair and nails. Both are described in the genetic and notes sections
  here only to keep the boundary of this entry explicit.
disease_term:
  preferred_term: FOXN1 deficiency (nude SCID)
  term:
    id: MONDO:0011132
    label: T-cell immunodeficiency, congenital alopecia, and nail dystrophy
parents:
- Severe combined immunodeficiency
- Primary immunodeficiency
- Congenital athymia
classifications:
  harrisons_chapter:
  - classification_value: IMMUNE_RHEUMATOLOGIC
    notes: >-
      Nude SCID is an inborn error of immunity presenting as severe combined
      immunodeficiency, so its primary clinical home is the immunology grouping.
    evidence:
    - reference: PMID:33464451
      reference_title: "Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Human nude SCID is a rare autosomal recessive inborn error of immunity
        (IEI) characterized by congenital athymia, alopecia, and nail dystrophy.
      explanation: >-
        Characterizes the disease as an inborn error of immunity, supporting
        placement in the immunology/rheumatology Part.
  - classification_value: GENETICS_ENVIRONMENT_DISEASE
    notes: >-
      Monogenic autosomal recessive disorder of a single transcription factor,
      with a documented founder mutation and carrier screening in an extended
      pedigree.
    evidence:
    - reference: PMID:28077132
      reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Nude severe combined immunodeficiency is a rare inherited disease caused
        by autosomal recessive loss-of-function mutations in FOXN1.
      explanation: >-
        Establishes the disease as a Mendelian, autosomal recessive single-gene
        condition.
  iuis_category:
    classification_value: combined immunodeficiency with syndromic features
    notes: >-
      IUIS 2022 phenotypic classification, Table 2 section 3 (thymic defects
      with additional congenital anomalies). The row cited here is the
      autosomal recessive "FOXN1 deficiency" entry (FOXN1, AR, OMIM 601705),
      which is this disease. The immediately following IUIS row, "FOXN1
      haploinsufficiency" (FOXN1, AD, OMIM 600838), is a separate and distinct
      entity - heterozygous carriers with severe T-cell lymphopenia at birth
      that normalises by adulthood, nail dystrophy, and no congenital athymia -
      and is NOT covered by this entry.
    evidence:
    - reference: PMID:35748970
      reference_title: "Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "FOXN1 deficiency FOXN1 AR 601705"
      explanation: >-
        The IUIS Table 2 thymic-defects row assigns FOXN1 deficiency to the
        combined immunodeficiency with syndromic features table, and records the
        autosomal recessive inheritance and OMIM 601705 identity that separate
        it from the adjacent AD haploinsufficiency row.
inheritance:
- name: Autosomal recessive
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >-
    Nude SCID is caused by biallelic loss-of-function variants in FOXN1.
    Heterozygous carriers of the R255X founder allele are healthy with respect
    to the full triad, which is what allowed a 6.52% carrier frequency to
    persist in the Acerno pedigree.
  evidence:
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Nude severe combined immunodeficiency is a rare inherited disease caused
      by autosomal recessive loss-of-function mutations in FOXN1.
    explanation: States the autosomal recessive, loss-of-function basis of the disease.
  - reference: PMID:8911612
    reference_title: "Congenital Alopecia and nail dystrophy associated with severe functional T-cell immunodeficiency in two sibs."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report on two sisters affected by congenital alopecia, nail dystrophy,
      and a severe T-cell immunodeficiency, presumably inherited as an
      autosomal-recessive disorder.
    explanation: >-
      The original clinical report of the syndrome in two affected sibs, from
      which autosomal recessive inheritance was inferred.
pathophysiology:
- name: FOXN1 Transcription Factor Loss of Function
  biological_scale: MOLECULAR
  description: >-
    Biallelic loss-of-function variants abolish FOXN1 transcription-factor
    activity. FOXN1 is a winged-helix (forkhead) DNA-binding transcription
    factor; the nonsense and frameshift alleles that cause human nude SCID
    remove or inactivate the DNA-binding domain, so the FOXN1 target gene
    program is not transcribed. This is the initiating lesion, and every
    downstream node - thymic and cutaneous alike - follows from the absence of
    this single transcriptional output rather than from any defect intrinsic to
    hematopoietic cells.
  genes:
  - preferred_term: FOXN1
    term:
      id: hgnc:12765
      label: FOXN1
  genetic_context:
    variant_origin: GERMLINE
    zygosity: HOMOZYGOUS
    functional_impact_category: LOSS_OF_FUNCTION
    description: >-
      Germline biallelic loss-of-function FOXN1 alleles; the prototype and most
      frequently reported allele is the nonsense variant R255X.
  molecular_functions:
  - preferred_term: FOXN1 winged-helix transcription factor activity
    term:
      id: GO:0003700
      label: DNA-binding transcription factor activity
    modifier: LOSS_OF_FUNCTION
  evidence:
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This gene encodes a transcription factor essential for the development of
      the thymus, the primary lymphoid organ that supports T-cell development
      and selection.
    explanation: >-
      Identifies FOXN1 as a transcription factor and establishes that its
      transcriptional output is what thymic development depends on.
  - reference: PMID:7969402
    reference_title: "New member of the winged-helix protein family disrupted in mouse and rat nude mutations."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Here we show that one of the genes from this critical region, designated
      whn, encodes a new member of the winged-helix domain family of
      transcription factors, and that it is disrupted on mouse nu and rat rnuN
      alleles.
    explanation: >-
      Identifies the nude gene as a winged-helix transcription factor, the
      molecular identity of FOXN1 and the origin of the "winged-helix-nude"
      name.
  - reference: PMID:7969402
    reference_title: "New member of the winged-helix protein family disrupted in mouse and rat nude mutations."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Mutant transcripts do not encode the characteristic DNA-binding domain,
      strongly suggesting that the whn gene is the nude gene.
    explanation: >-
      Establishes that the nude alleles act by removing the DNA-binding domain,
      i.e. by abolishing transcription-factor function.
  - reference: PMID:15180707
    reference_title: "Ancestral founder mutation of the nude (FOXN1) gene in congenital severe combined immunodeficiency associated with alopecia in southern Italy population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The first described human FOXN1 mutation was a C792T transition in exon 5
      resulting in the nonsense mutation R255X, and was detected in two probands
      originated from a small community in southern Italy.
    explanation: >-
      Documents the prototype human loss-of-function allele as a nonsense
      mutation.
  downstream:
  - target: Failed Thymic Epithelial Cell Differentiation
    causal_link_type: DIRECT
    description: >-
      FOXN1 is the master regulator of thymic epithelial identity; without its
      transcriptional program the thymic epithelial compartment does not
      differentiate.
    evidence:
    - reference: PMID:31447097
      reference_title: "Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "FOXN1 is the master regulatory gene of thymic epithelium development."
      explanation: >-
        Directly links loss of FOXN1 to failure of the thymic epithelial
        compartment.
  - target: Impaired Keratinocyte Terminal Differentiation
    causal_link_type: DIRECT
    description: >-
      The same transcription factor is expressed in terminally differentiating
      skin epithelium, so its loss simultaneously disrupts the keratinocyte
      growth-differentiation balance in hair follicle and nail bed. This is the
      parallel, non-immunological arm of the same molecular lesion.
    evidence:
    - reference: PMID:28077132
      reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        In the skin and its appendages FOXN1 is expressed in epithelial cells
        that have stopped proliferating and are in the process of terminal
        differentiation
      explanation: >-
        Establishes the cutaneous expression domain through which the same
        FOXN1 loss produces the ectodermal arm of the phenotype.
- name: Failed Thymic Epithelial Cell Differentiation
  biological_scale: CELLULAR
  description: >-
    Without FOXN1, thymic epithelial cells fail to differentiate into the
    cortical and medullary subsets that constitute the thymic microenvironment.
    Cortical TECs normally mediate positive selection of T-cell precursors and
    medullary TECs negative selection; neither compartment forms. This is a
    stromal, non-hematopoietic defect, which is the single most important
    mechanistic fact about the disease for treatment selection.
  cell_types:
  - preferred_term: thymic epithelial cell
    term:
      id: CL:0002293
      label: epithelial cell of thymus
  - preferred_term: cortical thymic epithelial cell
    term:
      id: CL:0002364
      label: cortical thymic epithelial cell
  - preferred_term: medullary thymic epithelial cell
    term:
      id: CL:0002365
      label: medullary thymic epithelial cell
  biological_processes:
  - preferred_term: thymic epithelial cell differentiation
    term:
      id: GO:0030855
      label: epithelial cell differentiation
    modifier: DECREASED
  - preferred_term: thymus epithelium morphogenesis
    term:
      id: GO:0097536
      label: thymus epithelium morphogenesis
    modifier: DECREASED
  locations:
  - preferred_term: thymus
    term:
      id: UBERON:0002370
      label: thymus
  evidence:
  - reference: PMID:31566583
    reference_title: "FOXN1 compound heterozygous mutations cause selective thymic hypoplasia in humans."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report on 2 patients with compound heterozygous mutations in forkhead
      box N1 (FOXN1), a transcription factor essential for thymic epithelial
      cell (TEC) differentiation.
    explanation: >-
      Identifies TEC differentiation as the FOXN1-dependent cellular process
      that fails.
  - reference: PMID:31566583
    reference_title: "FOXN1 compound heterozygous mutations cause selective thymic hypoplasia in humans."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Characterization of the functional changes due to the Foxn1 mutations
      revealed a 5-amino acid segment at the end of the DNA-binding domain
      essential for the development of TECs but not keratinocytes.
    explanation: >-
      Functional dissection showing that distinct parts of the FOXN1 DNA-binding
      domain are required for the thymic and cutaneous arms, which is why
      hypomorphic genotypes can dissociate the two.
  - reference: PMID:36648576
    reference_title: >-
      Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      the growth and differentiation of skin epithelial cells, including hair
      and nails
    explanation: >-
      In the thymic-defect guideline's FOXN1 section, this clause names the
      cutaneous half of the FOXN1-dependent epithelial program, alongside the
      thymic epithelial cells named in the preceding clause.
  downstream:
  - target: Athymia
    causal_link_type: DIRECT
    description: >-
      With no differentiated thymic epithelium there is no thymic organ to form;
      the result is congenital absence of a functional thymus.
    evidence:
    - reference: PMID:31447097
      reference_title: "Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        FOXN1 deficiency leads to thymic aplasia, alopecia, and nail dystrophy,
        accounting for the nude/severe combined immunodeficiency (nu/SCID)
        phenotype in humans and mice.
      explanation: >-
        Links loss of the FOXN1-dependent thymic epithelium to thymic aplasia.
- name: Athymia
  biological_scale: TISSUE
  description: >-
    Congenital absence of a functional thymus. This is thymic aplasia proper -
    the organ never forms - as distinguished from the thymic hypoplasia seen in
    hematopoietic-intrinsic SCID, where an epithelial rudiment is present but is
    not populated by thymocytes.
  locations:
  - preferred_term: thymus
    term:
      id: UBERON:0002370
      label: thymus
  biological_processes:
  - preferred_term: thymus development
    term:
      id: GO:0048538
      label: thymus development
    modifier: DECREASED
  evidence:
  - reference: PMID:20978268
    reference_title: "First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      FOXN1 deficiency is a primary immunodeficiency characterized by athymia,
      alopecia totalis, and nail dystrophy.
    explanation: Names athymia as the defining thymic lesion of FOXN1 deficiency.
  - reference: PMID:18339010
    reference_title: "FOXN1 homozygous mutation associated with anencephaly and severe neural tube defect in human athymic Nude/SCID fetus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified a human fetus homozygous for a mutation in FOXN1 gene who
      lacked the thymus and also had abnormal skin, anencephaly and spina bifida.
    explanation: >-
      Direct anatomical confirmation, in a homozygous human fetus, that the
      thymus is absent rather than merely small.
  downstream:
  - target: Absent Thymopoiesis
    causal_link_type: DIRECT
    description: >-
      Thymopoiesis requires the thymic microenvironment; with no thymus, T-cell
      precursors cannot undergo lineage commitment, positive selection, or
      negative selection.
    evidence:
    - reference: PMID:28077132
      reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        This gene encodes a transcription factor essential for the development
        of the thymus, the primary lymphoid organ that supports T-cell
        development and selection.
      explanation: >-
        States that the thymus is the organ supporting T-cell development, so
        its absence abolishes that process.
- name: Absent Thymopoiesis
  biological_scale: CELLULAR
  description: >-
    T-cell precursors arriving from the bone marrow have no thymic epithelial
    niche to interact with, so intrathymic T-cell differentiation does not
    occur. The hematopoietic stem cell compartment itself is normal - the block
    is entirely extrinsic to it.
  cell_types:
  - preferred_term: T cell
    term:
      id: CL:0000084
      label: T cell
  biological_processes:
  - preferred_term: T cell differentiation in thymus
    term:
      id: GO:0033077
      label: T cell differentiation in thymus
    modifier: DECREASED
  evidence:
  - reference: PMID:36648576
    reference_title: >-
      Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      leading to profound TCL. Affected individuals also have alopecia and
      dysplastic nails
    explanation: >-
      The guideline states that autosomal recessive FOXN1 deficiency blocks the
      interaction of T-cell precursors with cortical and medullary thymic
      epithelium, producing profound T-cell lymphopenia.
  - reference: PMID:20978268
    reference_title: "First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Subject 1 presented with disseminated Bacillus Calmette-Guérin infection
      and oligoclonal T cells with no naive markers.
    explanation: >-
      Absence of naive-marker T cells is the direct cellular readout of absent
      thymic output.
  downstream:
  - target: Profound T-Cell Lymphopenia
    causal_link_type: DIRECT
    description: >-
      With no thymic output, circulating T cells are absent or reduced to a few
      oligoclonal, transplacentally acquired or peripherally expanded cells.
    evidence:
    - reference: PMID:31447097
      reference_title: "Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        FOXN1 deficiency leads to thymic aplasia, alopecia, and nail dystrophy,
        accounting for the nude/severe combined immunodeficiency (nu/SCID)
        phenotype in humans and mice.
      explanation: >-
        Connects thymic aplasia to the SCID immunophenotype.
- name: Profound T-Cell Lymphopenia
  biological_scale: ORGANISM
  description: >-
    The immunophenotype is T-negative with numerically preserved B and NK cells
    (T-B+NK+). B cells are present but antibody production is compromised
    because T-cell help is absent, so humoral as well as cellular immunity
    fails despite a normal B-cell count. This is why the entity is a combined
    immunodeficiency rather than a pure T-cell defect.
  cell_types:
  - preferred_term: T cell
    term:
      id: CL:0000084
      label: T cell
  biological_processes:
  - preferred_term: T cell homeostasis
    term:
      id: GO:0043029
      label: T cell homeostasis
    modifier: DECREASED
  evidence:
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      To date nine cases have been reported presenting with the clinical triad
      of absent thymus resulting in severe T-cell immunodeficiency, congenital
      alopecia universalis and nail dystrophy.
    explanation: >-
      States that the severe T-cell immunodeficiency is the consequence of the
      absent thymus.
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Although B-cells are typically present in normal numbers, antibody
      production is compromised in the absence of T-cell help
    explanation: >-
      Documents the B+ immunophenotype and explains why preserved B-cell numbers
      do not confer functional humoral immunity.
  downstream:
  - target: Severe Recurrent Infection
    causal_link_type: DIRECT
    description: >-
      Loss of T-cell-mediated immunity, compounded by the failure of
      T-dependent antibody responses, leaves the infant defenceless against
      viral, fungal, opportunistic and encapsulated-bacterial pathogens and
      against live vaccines.
    evidence:
    - reference: PMID:28077132
      reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        All reported patients presented in the first months of life with severe,
        recurrent, life-threatening infections
      explanation: >-
        Links the T-cell defect to the presenting infectious phenotype and its
        timing.
- name: Severe Recurrent Infection
  biological_scale: ORGANISM
  description: >-
    Severe, recurrent, life-threatening infection beginning in the first months
    of life is the presenting feature and, untreated, the cause of death.
    Disseminated BCG disease has been reported where BCG was given before the
    immunodeficiency was recognised.
  biological_processes:
  - preferred_term: defense response
    term:
      id: GO:0006952
      label: defense response
    modifier: DECREASED
  evidence:
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Without these the prognosis is poor due to early-onset life threatening
      infections.
    explanation: >-
      Establishes early-onset life-threatening infection as the cause of the
      poor untreated prognosis.
  - reference: PMID:15180707
    reference_title: "Ancestral founder mutation of the nude (FOXN1) gene in congenital severe combined immunodeficiency associated with alopecia in southern Italy population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In this community, four additional children affected with congenital
      alopecia died in early childhood because of severe infections.
    explanation: >-
      Documents early-childhood death from severe infection in affected members
      of the founder pedigree.
- name: Impaired Keratinocyte Terminal Differentiation
  biological_scale: CELLULAR
  description: >-
    FOXN1 is expressed in skin epithelial cells that have exited the cell cycle
    and are undergoing terminal differentiation, where it controls expression of
    kinases governing cell survival, metabolism and cell-cycle progression. Its
    loss disrupts the balance between growth and differentiation in these cells.
    Notably, hair follicles are present in normal numbers - the defect is in the
    differentiated product, not in follicle formation.
  cell_types:
  - preferred_term: keratinocyte
    term:
      id: CL:0000312
      label: keratinocyte
  biological_processes:
  - preferred_term: keratinocyte differentiation
    term:
      id: GO:0030216
      label: keratinocyte differentiation
    modifier: DECREASED
  - preferred_term: hair follicle development
    term:
      id: GO:0001942
      label: hair follicle development
    modifier: DECREASED
  evidence:
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In the skin and its appendages FOXN1 is expressed in epithelial cells that
      have stopped proliferating and are in the process of terminal
      differentiation
    explanation: >-
      Locates FOXN1 function in terminally differentiating skin epithelium.
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      As a consequence, loss-of-function mutations disrupt the balance between
      normal growth and differentiation of these cells
    explanation: >-
      States the cellular consequence of FOXN1 loss in keratinocytes.
  - reference: PMID:7969402
    reference_title: "New member of the winged-helix protein family disrupted in mouse and rat nude mutations."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Mutations at the nude locus of mice and rats disrupt normal hair growth
      and thymus development, causing nude mice and rats to be immune-deficient.
    explanation: >-
      The animal nude phenotype couples the same two arms - hair and thymus -
      confirming a shared single-gene origin.
  downstream:
  - target: Congenital Alopecia Universalis
    causal_link_type: DIRECT
    description: >-
      Defective terminal differentiation of follicular keratinocytes yields
      structurally abnormal hair shafts from numerically normal follicles,
      manifesting as alopecia present from birth.
    evidence:
    - reference: PMID:31447097
      reference_title: "Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        FOXN1 deficiency leads to thymic aplasia, alopecia, and nail dystrophy,
        accounting for the nude/severe combined immunodeficiency (nu/SCID)
        phenotype in humans and mice.
      explanation: Links FOXN1 deficiency to alopecia.
  - target: Nail Dystrophy
    causal_link_type: DIRECT
    description: >-
      The same keratinocyte differentiation defect in the nail bed produces the
      characteristic nail plate abnormalities.
    evidence:
    - reference: PMID:31447097
      reference_title: "Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        FOXN1 deficiency leads to thymic aplasia, alopecia, and nail dystrophy,
        accounting for the nude/severe combined immunodeficiency (nu/SCID)
        phenotype in humans and mice.
      explanation: Links FOXN1 deficiency to nail dystrophy.
phenotypes:
- category: Immunologic
  name: Profound T-Cell Lymphopenia
  description: >-
    T cells are absent or severely reduced, with B and NK cells numerically
    preserved (T-B+NK+). Newborn screening shows very low or absent T-cell
    receptor excision circles.
  phenotype_term:
    preferred_term: Decreased total T cell count
    term:
      id: HP:0005403
      label: Decreased total T cell count
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:20978268
    reference_title: "First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Subject 2 had respiratory failure, human herpes virus 6 infection, cytopenias, and no circulating T cells."
    explanation: >-
      Documents complete absence of circulating T cells in a FOXN1-deficient
      infant.
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      To date nine cases have been reported presenting with the clinical triad
      of absent thymus resulting in severe T-cell immunodeficiency, congenital
      alopecia universalis and nail dystrophy.
    explanation: >-
      Severe T-cell immunodeficiency is one of the three defining features
      present in every reported case, supporting a very frequent band.
- category: Immunologic
  name: Severe Combined Immunodeficiency Phenotype
  description: >-
    The combination of absent T-cell immunity with functionally absent
    T-dependent antibody responses constitutes severe combined immunodeficiency,
    notwithstanding normal B-cell numbers.
  phenotype_term:
    preferred_term: Severe combined immunodeficiency
    term:
      id: HP:0004430
      label: Severe combined immunodeficiency
  evidence:
  - reference: PMID:33464451
    reference_title: "Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Human nude SCID is a rare autosomal recessive inborn error of immunity
      (IEI) characterized by congenital athymia, alopecia, and nail dystrophy.
    explanation: Establishes the SCID classification of the disease.
- category: Immunologic
  name: Severe Recurrent Infection from Birth
  description: >-
    All reported patients present in the first months of life with severe,
    recurrent, life-threatening infections, including viral, fungal and
    opportunistic organisms, encapsulated bacteria, and disseminated disease
    after live vaccines such as BCG.
  phenotype_term:
    preferred_term: Recurrent severe infections
    term:
      id: HP:0002719
      label: Recurrent infections
    temporality: RECURRENT
    severity: SEVERE
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All reported patients presented in the first months of life with severe,
      recurrent, life-threatening infections
    explanation: >-
      "All reported patients" supports the very frequent (80-100%) band as well
      as the phenotype itself.
  - reference: PMID:20978268
    reference_title: "First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Subject 1 presented with disseminated Bacillus Calmette-Guérin infection
      and oligoclonal T cells with no naive markers.
    explanation: >-
      Illustrates disseminated live-vaccine (BCG) disease as a presenting
      infection.
- category: Imaging
  name: Athymia
  description: >-
    Congenital absence of the thymus, confirmed anatomically in a homozygous
    fetus and inferred clinically from absent thymic shadow with absent naive
    T cells.
  phenotype_term:
    preferred_term: Aplasia of the thymus
    term:
      id: HP:0005359
      label: Aplasia of the thymus
  frequency: VERY_FREQUENT
  notes: >-
    Aplasia, not hypoplasia: in FOXN1 deficiency the thymic epithelial
    primordium fails to differentiate, so the organ does not form. This is the
    distinction drawn in the Severe_Combined_Immunodeficiency entry, where
    HP:0000778 Hypoplasia of the thymus is used because a rudiment is present
    but unpopulated.
  evidence:
  - reference: PMID:18339010
    reference_title: "FOXN1 homozygous mutation associated with anencephaly and severe neural tube defect in human athymic Nude/SCID fetus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified a human fetus homozygous for a mutation in FOXN1 gene who
      lacked the thymus and also had abnormal skin, anencephaly and spina bifida.
    explanation: Anatomical confirmation of absent thymus in a homozygous human fetus.
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      To date nine cases have been reported presenting with the clinical triad
      of absent thymus resulting in severe T-cell immunodeficiency, congenital
      alopecia universalis and nail dystrophy.
    explanation: >-
      Absent thymus is one of the three features present in the reported case
      series, supporting the very frequent band.
- category: Dermatologic
  name: Congenital Alopecia Universalis
  description: >-
    Alopecia present from birth affecting scalp, eyebrows and eyelashes. Hair
    follicles are numerically normal but produce structurally abnormal hair.
  phenotype_term:
    preferred_term: Congenital alopecia universalis
    term:
      id: HP:0002289
      label: Alopecia universalis
    onset:
      onset_category: CONGENITAL
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Dermatological features include congenital alopecia affecting the scalp,
      eyebrows and eyelashes
    explanation: Documents the distribution of the congenital alopecia.
  - reference: PMID:8911612
    reference_title: "Congenital Alopecia and nail dystrophy associated with severe functional T-cell immunodeficiency in two sibs."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report on two sisters affected by congenital alopecia, nail dystrophy,
      and a severe T-cell immunodeficiency, presumably inherited as an
      autosomal-recessive disorder.
    explanation: The original report establishing congenital alopecia as a core feature.
  notes: >-
    Not invariant. In a large international survey of FOXN1 genotypes, alopecia
    and nail dystrophy were "not always present", so the very frequent band
    reflects the classic triad rather than a universal finding.
- category: Dermatologic
  name: Nail Dystrophy
  description: >-
    Dystrophic nails present from birth, most frequently proximal arciform
    leukonychia and koilonychia, though canaliform dystrophy and Beau's lines
    have also been described.
  phenotype_term:
    preferred_term: Nail dystrophy
    term:
      id: HP:0008404
      label: Nail dystrophy
    onset:
      onset_category: CONGENITAL
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The latter most frequently features proximal arciform leukonychia and
      koilonychia
    explanation: Specifies the characteristic nail changes.
  - reference: PMID:20978268
    reference_title: "First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      FOXN1 deficiency is a primary immunodeficiency characterized by athymia,
      alopecia totalis, and nail dystrophy.
    explanation: Nail dystrophy is one of the three characterizing features.
- category: Dermatologic
  name: Leukonychia
  description: >-
    Proximal arciform leukonychia (white banding of the nail plate) is the most
    frequent specific nail change.
  phenotype_term:
    preferred_term: Proximal arciform leukonychia
    term:
      id: HP:0001820
      label: Leukonychia
  evidence:
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The latter most frequently features proximal arciform leukonychia and
      koilonychia
    explanation: Names proximal arciform leukonychia as a most-frequent nail finding.
- category: Dermatologic
  name: Koilonychia
  description: >-
    Spoon-shaped (concave) nails, reported alongside leukonychia as the most
    frequent nail dystrophy pattern.
  phenotype_term:
    preferred_term: Koilonychia
    term:
      id: HP:0001598
      label: Concave nail
  evidence:
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The latter most frequently features proximal arciform leukonychia and
      koilonychia
    explanation: Names koilonychia as a most-frequent nail finding.
- category: Immunologic
  name: Omenn Syndrome Features
  description: >-
    A substantial minority of patients develop Omenn syndrome, an inflammatory
    state driven by expansion of autoreactive oligoclonal T cells in the setting
    of SCID, presenting with erythroderma, hepatosplenomegaly, lymphadenopathy,
    diarrhoea, failure to thrive, eosinophilia and elevated IgE.
  phenotype_term:
    preferred_term: Erythroderma (Omenn-like presentation)
    term:
      id: HP:0001019
      label: Erythroderma
  frequency: FREQUENT
  evidence:
  - reference: PMID:33464451
    reference_title: "Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Nail dystrophy and alopecia, that represent the hallmarks of the syndrome,
      were not always present, while almost 50% of the patients developed Omenn
      syndrome.
    explanation: >-
      Quantifies Omenn syndrome at almost 50% of the surveyed cohort, supporting
      the frequent (30-79%) band, and simultaneously documents that the
      dermatological hallmarks are not invariant.
- category: Neurologic
  name: Neural Tube Defect
  description: >-
    Neural tube defects have been described in two fetuses from the Acerno
    kindred, one with anencephaly and spina bifida. FOXN1 is expressed in mouse
    developing choroid plexus, suggesting a role in neurulation. This is a rare
    finding restricted to a single pedigree and should not be expected in every
    patient.
  phenotype_term:
    preferred_term: Neural tube defect
    term:
      id: HP:0045005
      label: Neural tube defect
  frequency: VERY_RARE
  evidence:
  - reference: PMID:18339010
    reference_title: "FOXN1 homozygous mutation associated with anencephaly and severe neural tube defect in human athymic Nude/SCID fetus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified a human fetus homozygous for a mutation in FOXN1 gene who
      lacked the thymus and also had abnormal skin, anencephaly and spina bifida.
    explanation: >-
      Documents anencephaly and spina bifida in a homozygous FOXN1 fetus.
  - reference: PMID:18339010
    reference_title: "FOXN1 homozygous mutation associated with anencephaly and severe neural tube defect in human athymic Nude/SCID fetus."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Moreover, we found that FOXN1 gene is expressed in mouse developing
      choroid plexus. These observations suggest that FOXN1 may be involved in
      neurulation in humans.
    explanation: >-
      Provides the model-organism expression evidence behind the proposed role
      in neurulation. Indirect: the quote reports mouse choroid-plexus
      expression and an inference, not an observed human neural tube defect,
      which rests on the fetal case in the companion evidence item.
- category: Neurologic
  name: Anencephaly
  description: >-
    Anencephaly was present in one homozygous FOXN1 fetus from the Acerno
    kindred, together with spina bifida.
  phenotype_term:
    preferred_term: Anencephaly
    term:
      id: HP:0002323
      label: Anencephaly
  frequency: VERY_RARE
  evidence:
  - reference: PMID:18339010
    reference_title: "FOXN1 homozygous mutation associated with anencephaly and severe neural tube defect in human athymic Nude/SCID fetus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified a human fetus homozygous for a mutation in FOXN1 gene who
      lacked the thymus and also had abnormal skin, anencephaly and spina bifida.
    explanation: Documents anencephaly in a homozygous FOXN1 fetus.
genetic:
- name: FOXN1
  gene_term:
    preferred_term: FOXN1
    term:
      id: hgnc:12765
      label: FOXN1
  association: CAUSATIVE
  relationship_type: CAUSATIVE
  notes: >-
    Biallelic loss-of-function FOXN1 variants cause nude SCID. Reported alleles
    include the founder nonsense variant R255X (c.792C>T, exon 5), R320W, and
    S188fs. R255X accounts for most reported patients, all descending from a
    single 19th-century ancestral couple in Acerno, southern Italy; the same
    allele was later found in a Portuguese child of consanguineous parents.

    Scope note on other FOXN1 genotypes, which are NOT this disease. Monoallelic
    FOXN1 loss-of-function (FOXN1 haploinsufficiency, autosomal dominant,
    OMIM 600838) is ascertained through low TRECs at newborn screening and
    causes T-cell lymphopenia that improves with age, with normal or nearly
    normal hair and only subtle nail dystrophy (spoon nails), and generally no
    congenital athymia. Compound heterozygous hypomorphic genotypes can produce
    selective thymic hypoplasia with a T-/loB+NK+ SCID presentation and
    completely normal hair and nails. IUIS lists FOXN1 haploinsufficiency as its
    own row, distinct from the AR FOXN1 deficiency row that this entry curates.

    Historical note on the founding human report. Frank et al., Nature 1999
    (PMID:10206641, "Exposing the human nude phenotype") identified FOXN1 as the
    gene mutated in the human nude phenotype and is listed in the top-level
    references block. Its cached PubMed record carries no abstract text, so no
    exact-quote snippet can be drawn from it, and it is deliberately not used as
    an evidence item anywhere in this entry.
  evidence:
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Nude severe combined immunodeficiency is a rare inherited disease caused
      by autosomal recessive loss-of-function mutations in FOXN1.
    explanation: >-
      Establishes FOXN1 as the causative gene and loss of function as the
      mechanism.
  - reference: PMID:15180707
    reference_title: "Ancestral founder mutation of the nude (FOXN1) gene in congenital severe combined immunodeficiency associated with alopecia in southern Italy population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The first described human FOXN1 mutation was a C792T transition in exon 5
      resulting in the nonsense mutation R255X, and was detected in two probands
      originated from a small community in southern Italy.
    explanation: Identifies the prototype human allele and its geographic origin.
  - reference: PMID:15180707
    reference_title: "Ancestral founder mutation of the nude (FOXN1) gene in congenital severe combined immunodeficiency associated with alopecia in southern Italy population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The three haplotypes identified, 3/R255X/3, 3/R255X/2 and 3/R255X/1, are
      consistent with a single ancestral origin for the mutation R255X.
    explanation: >-
      Haplotype analysis establishing R255X as a single ancestral founder
      allele.
- name: FOXN1 (heterozygous - distinct entity, not this disease)
  gene_term:
    preferred_term: FOXN1
    term:
      id: hgnc:12765
      label: FOXN1
  association: MODIFIER
  relationship_type: MODIFIER
  notes: >-
    Recorded for boundary clarity only. Monoallelic FOXN1 loss-of-function is a
    separate autosomal dominant entity (FOXN1 haploinsufficiency, OMIM 600838,
    its own IUIS row) and is NOT the disease curated here. It is included in
    this section so that a curator or reader encountering a heterozygous FOXN1
    result is not led to this entry by default. Its immunophenotype is milder
    and age-limited, and the ectodermal features are minimal.
  evidence:
  - reference: PMID:31447097
    reference_title: "Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified several newborns with low levels of T cell receptor excision
      circles (TRECs) and T cell lymphopenia at birth, who carried heterozygous
      loss-of-function FOXN1 variants.
    explanation: >-
      Documents the heterozygous newborn-screening phenotype that defines the
      separate haploinsufficiency entity.
  - reference: PMID:31447097
    reference_title: "Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Longitudinal analysis showed persistent T cell lymphopenia during infancy,
      often associated with nail dystrophy.
    explanation: >-
      Characterizes the milder, age-limited heterozygous phenotype, distinct
      from the congenital athymia of the recessive disease.
  - reference: PMID:36648576
    reference_title: >-
      Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Congenital athymia is generally not present, and individuals have normal
      or almost normal appearing hair with only subtle nail dystrophy (spoon
      nails).
    explanation: >-
      The guideline states explicitly that heterozygous FOXN1 carriers lack the
      athymia and the ectodermal hallmarks that define this entry's disease.
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    Ultra-rare. As of the 2017 disease review, nine cases had been reported in
    the literature, six of them from the single Acerno founder pedigree in
    southern Italy. Newborn screening and next-generation sequencing have since
    identified additional and atypical cases, so the true incidence is thought
    to be higher than the historical case count implies. Orphanet code
    ORPHA:169095; no ORPHA structured cache entry was built for this entry.
  evidence:
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Nude severe combined immunodeficiency is a rare inherited disease caused by autosomal
      recessive loss-of-function mutations in FOXN1. This gene encodes a transcription factor
      essential for the development of the thymus, the primary lymphoid organ that supports T-cell
      development and selection. To date nine cases have been reported presenting with the clinical
      triad of absent thymus resulting in severe T-cell immunodeficiency, congenital alopecia
      universalis and nail dystrophy. ... Six patients originated from Acerno in southern Italy; all
      had the same homozygous founder mutation (R255X)
    explanation: >-
      The review reports nine FOXN1-associated nude SCID cases, including six from Acerno with the
      same founder mutation. The quoted count is the literature available to that review.
  - reference: PMID:33464451
    reference_title: "Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      However, the recent introduction of newborn screening for IEIs and
      high-throughput sequencing has led to the identification of novel and
      atypical cases.
    explanation: >-
      Supports this record's caveat that ascertainment has improved, so
      published case totals understate true occurrence. Indirect: the quote
      speaks to the completeness of case finding rather than reporting any
      occurrence figure of its own.
- population: Acerno, southern Italy (R255X carrier screening)
  measure_type: CARRIER_FREQUENCY
  prevalence_class: ABOVE_1_IN_1000
  rate_per_100000: 6520.0
  notes: >-
    Carrier frequency of the R255X founder allele, not disease prevalence:
    55 heterozygous carriers among 843 screened inhabitants (6.52%), all linked
    in a seven-generation pedigree descending from one ancestral couple.
  evidence:
  - reference: PMID:15180707
    reference_title: "Ancestral founder mutation of the nude (FOXN1) gene in congenital severe combined immunodeficiency associated with alopecia in southern Italy population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This analysis led us to identify 55 heterozygous carriers (6.52%) of the
      R255X mutation out of 843 inhabitants screened.
    explanation: >-
      Directly reports the carrier count, denominator and percentage behind this
      carrier-frequency record.
treatments:
- name: Cultured Thymus Tissue Implantation
  description: >-
    Implantation of cultured allogeneic postnatal thymus tissue (obtained from
    infants undergoing corrective cardiac surgery) into the quadriceps muscle.
    This is the mechanism-directed treatment for nude SCID: because FOXN1 is
    expressed in thymic epithelium and not in hematopoietic cells, supplying a
    functional thymic stromal environment - rather than replacing the patient's
    own normal hematopoietic compartment - is what restores thymopoiesis. HLA
    matching is not required. Reconstitution is slow, typically taking six to
    twelve months, so supportive infection prophylaxis must bridge that
    interval. Autoimmunity, principally thyroid, is a recognised late
    complication.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: cultured thymus tissue implantation
    term:
      id: NCIT:C15289
      label: Organ Transplantation
  target_phenotypes:
  - preferred_term: Aplasia of the thymus
    term:
      id: HP:0005359
      label: Aplasia of the thymus
  - preferred_term: Decreased total T cell count
    term:
      id: HP:0005403
      label: Decreased total T cell count
  target_mechanisms:
  - target: Athymia
    treatment_effect: RESTORES
    description: >-
      The implant supplies the thymic epithelial microenvironment the patient
      never formed, directly addressing the athymia node rather than any
      hematopoietic step.
    evidence:
    - reference: PMID:28077132
      reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Given that FOXN1 is expressed in TECs and not haematopoietic cells,
        establishing a functional thymic stromal environment is expected to
        provide more complete and long-lasting immune reconstitution
      explanation: >-
        States the mechanistic rationale for treating the stromal defect
        directly.
  - target: Absent Thymopoiesis
    treatment_effect: RESTORES
    description: >-
      Once a thymic microenvironment is present, host T-cell precursors undergo
      normal intrathymic development, producing naive T cells and TREC-positive
      recent thymic emigrants.
    evidence:
    - reference: PMID:20978268
      reference_title: "First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        In summary, thymus transplantation led to T-cell reconstitution and
        function in these FOXN1 deficient infants.
      explanation: >-
        Demonstrates restored thymopoiesis in the two FOXN1-deficient infants
        treated.
  evidence:
  - reference: PMID:20978268
    reference_title: "First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Two infants with FOXN1 deficiency were transplanted with cultured postnatal thymus tissue."
    explanation: >-
      The first application of cultured thymus tissue specifically in FOXN1
      deficiency.
  - reference: PMID:20978268
    reference_title: "First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Both subjects developed functional immunity. Subjects 1 and 2 have
      1053/mm(3) and 1232/mm(3) CD3(+) cells
    explanation: >-
      Quantifies the reconstituted T-cell compartment achieved in both treated
      FOXN1-deficient infants.
  - reference: PMID:34362576
    reference_title: "Experience with cultured thymus tissue in 105 children."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Treatment with CTT led to development of naive T cells with a 1-year
      survival rate of 77% and a median follow-up time of 7.6 years.
    explanation: >-
      Provides the pooled efficacy and survival estimate across the full
      congenital-athymia cohort, which includes FOXN1 deficiency.
  - reference: PMID:34362576
    reference_title: "Experience with cultured thymus tissue in 105 children."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Immune reconstitution sufficient to prevent infections and support
      survival typically develops 6 to12 months after administration of CTT.
    explanation: >-
      Establishes the months-long reconstitution interval that supportive care
      must bridge.
  - reference: PMID:20978268
    reference_title: "First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases."
    supports: SUPPORT
    directness: DIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Subject 2 developed autoimmune thyroid disease 1.6 years after transplantation."
    explanation: >-
      Supports this treatment's stated late complication: a directly observed
      case of post-implantation thyroid autoimmunity in one of the two treated
      FOXN1-deficient infants.
  notes: >-
    The IUIS/thymic-defect literature reports these outcomes for congenital
    athymia as a whole (complete DiGeorge, CHARGE, FOXN1 deficiency and others).
    The FOXN1-specific experience remains two published infants; the 105-child
    cohort figures are cohort-level, not FOXN1-specific, and are cited as such.
- name: Hematopoietic Cell Transplantation
  description: >-
    Allogeneic HCT does not correct the underlying lesion, because FOXN1 is
    expressed in thymic stroma and not in hematopoietic cells - transplanting
    normal stem cells into a patient with no thymus leaves them with nowhere to
    differentiate. Where HCT has helped in nude SCID, the benefit is attributed
    to mature donor T cells carried in the graft rather than to restored
    thymopoiesis, which is why the literature restricts it to HLA-matched
    genoidentical sibling donors, and why it is preferred chiefly when
    thymus tissue is unavailable or when rapid T-cell recovery is needed for a
    pre-existing systemic viral infection. Outcomes reported for athymia treated
    with HCT are poor.
  therapeutic_modality: CELL_THERAPY
  treatment_term:
    preferred_term: hematopoietic cell transplantation
    term:
      id: NCIT:C15431
      label: Hematopoietic Cell Transplantation
  target_mechanisms:
  - target: Profound T-Cell Lymphopenia
    treatment_effect: MODULATES
    description: >-
      A genoidentical graft can supply mature donor T cells that partially
      populate the periphery. It does not act on the athymia or the thymopoiesis
      block upstream of it, so the effect is compensatory rather than
      restorative.
    evidence:
    - reference: PMID:28077132
      reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        whereas the other was alive and infection-free when assessed 6 years
        later likely due to the presence of mature donor T-cells
      explanation: >-
        Describes the surviving HCT recipient among the two treated; the review
        attributes the outcome to mature donor T cells present in the bone
        marrow graft rather than to restored thymic function — the mechanistic
        point behind typing this treatment MODULATES rather than RESTORES.
  evidence:
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Options for treating the underlying immune deficiency include HLA-matched
      genoidentical haematopoietic cell transplantation containing mature donor
      T-cells or thymus tissue transplantation.
    explanation: >-
      Identifies the two definitive options and specifies that the HCT option
      depends on mature donor T cells in the graft.
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Given that FOXN1 is expressed in TECs and not haematopoietic cells,
      establishing a functional thymic stromal environment is expected to
      provide more complete and long-lasting immune reconstitution
    explanation: >-
      States why replacing the hematopoietic compartment is not expected to
      provide complete reconstitution in a thymic stromal defect.
  - reference: PMID:34362576
    reference_title: "Experience with cultured thymus tissue in 105 children."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      only 7 of 17 patients (41%) were reported as surviving by Janda et al.
    explanation: >-
      Reports the survival figure for congenital athymia treated with
      hematopoietic stem cell transplantation, the comparator against which
      cultured thymus tissue is assessed. Indirect because this is the
      congenital-athymia cohort broadly, not a FOXN1-only series.
  - reference: PMID:36648576
    reference_title: >-
      Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development.
    supports: REFUTE
    evidence_source: OTHER
    snippet: >-
      did not prove effective for children affected with biallelic FOXN1
      deficiency
    explanation: >-
      The thymic-defect guideline states that bone marrow transplantation was
      not effective in biallelic FOXN1 deficiency, refuting HCT as a
      mechanism-correcting therapy for this disease.
- name: Infection Prophylaxis and Protective Isolation
  description: >-
    Supportive management that bridges the interval before and after definitive
    treatment: protective isolation in a laminar-flow room, prophylaxis against
    Pneumocystis jirovecii, fungal and viral infection, and anti-mycobacterial
    treatment for any infant already immunised with BCG. Live vaccines are
    contraindicated. Blood products, if required, must be CMV-negative,
    irradiated and leucocyte-depleted.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: antimicrobial prophylaxis
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  target_mechanisms:
  - target: Severe Recurrent Infection
    treatment_effect: INHIBITS
    description: >-
      Prophylaxis and isolation act on the infectious consequence of the
      immunodeficiency; they do not touch the thymic lesion upstream.
    evidence:
    - reference: PMID:34362576
      reference_title: "Experience with cultured thymus tissue in 105 children."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Currently, the only available treatment for these patients, outside of a
        clinical trial, is supportive care, which may include strict
        infection-prevention measures including immunoglobulin replacement,
        prophylactic antimicrobials, and protective isolation.
      explanation: >-
        Names the supportive components and their role in congenital athymia
        outside definitive therapy.
  evidence:
  - reference: PMID:34362576
    reference_title: "Experience with cultured thymus tissue in 105 children."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Currently, the only available treatment for these patients, outside of a
      clinical trial, is supportive care, which may include strict
      infection-prevention measures including immunoglobulin replacement,
      prophylactic antimicrobials, and protective isolation.
    explanation: >-
      Establishes supportive infection prevention as the standing management for
      congenital athymia.
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This involves isolation in a laminar flow room, prophylaxis against
    explanation: >-
      The disease review specifies laminar-flow isolation and infection
      prophylaxis as the supportive regimen for nude SCID.
- name: Immunoglobulin Replacement Therapy
  description: >-
    Immunoglobulin replacement compensates for the absent T-dependent antibody
    response. B cells are numerically normal in nude SCID, so the humoral defect
    is functional rather than quantitative; replacement addresses that
    functional gap and can be discontinued once thymic reconstitution restores
    T-cell help.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: immunoglobulin replacement therapy
    term:
      id: NCIT:C62710
      label: Immunoglobulin Therapy
  target_mechanisms:
  - target: Profound T-Cell Lymphopenia
    treatment_effect: MODULATES
    description: >-
      Replacement immunoglobulin substitutes for the antibody responses the
      patient cannot mount without T-cell help. It compensates for a downstream
      consequence and does not alter the thymic lesion.
    evidence:
    - reference: PMID:20978268
      reference_title: "First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Both subjects developed antigen-specific proliferative responses and
        have discontinued immunoglobulin replacement.
      explanation: >-
        Shows that immunoglobulin replacement was the standing substitute for
        T-dependent antibody responses and became unnecessary once thymic
        function was restored.
  evidence:
  - reference: PMID:34362576
    reference_title: "Experience with cultured thymus tissue in 105 children."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Currently, the only available treatment for these patients, outside of a
      clinical trial, is supportive care, which may include strict
      infection-prevention measures including immunoglobulin replacement,
      prophylactic antimicrobials, and protective isolation.
    explanation: >-
      Names immunoglobulin replacement as a component of supportive care in
      congenital athymia.
- name: Genetic Counseling and Carrier Testing
  description: >-
    FOXN1 sequencing establishes the diagnosis, guides therapeutic management,
    and enables counselling. In the Acerno pedigree, targeted PCR for the known
    R255X allele supported population-level carrier screening.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:28077132
    reference_title: "FOXN1 deficient nude severe combined immunodeficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Diagnosis relies on testing for FOXN1 mutations, which allows genetic
      counselling and guides therapeutic management.
    explanation: >-
      States the role of molecular diagnosis in counselling and management.
  - reference: PMID:15180707
    reference_title: "Ancestral founder mutation of the nude (FOXN1) gene in congenital severe combined immunodeficiency associated with alopecia in southern Italy population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In this study, we report on the screening for this mutation in 30% of the
      village population.
    explanation: >-
      Documents founder-allele carrier screening at population scale in the
      affected community.
references:
- reference: PMID:10206641
  title: "Exposing the human nude phenotype."
📚

References & Deep Research

References

1
Exposing the human nude phenotype.
No top-level findings curated for this source.